Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL36A pseudogene 52 (RPL36AP52) is a processed pseudogene that resembles RPL36A, which encodes a component of the large (60S) ribosomal subunit involved in protein synthesis. Unlike RPL36A, RPL36AP52 is not known to encode a functional protein, is not implicated in any known biological pathways, and is not considered a therapeutic or drug target[4]. RPL36AP52 should not be confused with the protein-coding RPL36A gene, which has roles in ribosome function and may be involved in cell growth and certain cancers[1][2][3], whereas RPL36AP52 is a non-coding pseudogene and is not a molecular target by conventional criteria[4]. There are no reported disease associations, therapeutic uses, interacting drugs, or biomarker roles for RPL36AP52[4]. Its main biological significance is as a processed genomic copy—pseudogenes like RPL36AP52 may have regulatory functions at the RNA level, but no such role is currently established for this entry[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPL36A pseudogene 52 (RPL36AP52).